763 related articles for article (PubMed ID: 29411768)
1. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators: indications and unresolved issues.
Kedia R; Saeed M
Tex Heart Inst J; 2012; 39(3):335-41. PubMed ID: 22719141
[TBL] [Abstract][Full Text] [Related]
3. Evidence rather than costs must guide use of the implantable cardioverter defibrillator.
Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L
Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
5. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
Thavikulwat AC; Tomson TT; Knight BP; Bonow RO; Choudhury L
J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing.
Payne JE; Badertscher P; Field ME; Sturdivant JL; Gold MR
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008631. PubMed ID: 32703008
[No Abstract] [Full Text] [Related]
8. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.
Tsai VW; Cooper J; Garan H; Natale A; Ptaszek LM; Ellinor PT; Hickey K; Downey R; Zei P; Hsia H; Wang P; Hunt S; Haddad F; Al-Ahmad A
Circ Heart Fail; 2009 May; 2(3):197-201. PubMed ID: 19808340
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in the subcutaneous ICD.
Willcox ME; Prutkin JM; Bardy GH
Trends Cardiovasc Med; 2016 Aug; 26(6):526-35. PubMed ID: 27079889
[TBL] [Abstract][Full Text] [Related]
10. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.
Viani S; Soldati E; DI Cori A; Segreti L; Paperini L; DE Lucia R; Zucchelli G; Bongiorni MG
Minerva Cardioangiol; 2018 Feb; 66(1):83-99. PubMed ID: 28696089
[TBL] [Abstract][Full Text] [Related]
11. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
12. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
13. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
[TBL] [Abstract][Full Text] [Related]
14. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
[No Abstract] [Full Text] [Related]
15. Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.
Souza FSO; Matos VS; Almeida MCV; Weiss SC; Rodrigues LHB; Lima PAG; Mattos DB
Braz J Cardiovasc Surg; 2017; 32(6):498-502. PubMed ID: 29267613
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
17. Clinical management and prevention of sudden cardiac death.
Yousuf O; Chrispin J; Tomaselli GF; Berger RD
Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
19. "Real life" longevity of implantable cardioverter-defibrillator devices.
Manolis AS; Maounis T; Koulouris S; Vassilikos V
Clin Cardiol; 2017 Sep; 40(9):759-764. PubMed ID: 28543134
[TBL] [Abstract][Full Text] [Related]
20. Underdetection of Ventricular Fibrillation by Wearable Cardioverter-Defibrillator Leading to Sudden Death.
Kokubun H; Miyauchi Y; Inada S; Shimizu W
Circ J; 2020 Dec; 85(1):79. PubMed ID: 33208580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
